Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Nelfinavir × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Gastrointestinal 2 Tumor-Agnostic 1 Sarcoma 1 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Prostate Cancer Recurrent 1 Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 24 Docetaxel 19 Gemcitabine 15 Paclitaxel 13 Prednisone 11 Nivolumab 11 pazopanib 10 Sorafenib 9 Radiotherapy 9 Therapeutics 7 Leuprolide 7 Ipilimumab 7 Cyclophosphamide 7 Cisplatin 7 Carboplatin 7 Blood Specimen Collection 7 Bevacizumab 7 avelumab 6 atezolizumab 6 Thalidomide 6 Sunitinib 6 Radiation 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 Standard of Care 5 Radiosurgery 5 Denosumab 5 temsirolimus 4 padeliporfin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01079286 2013-07-15

I-NET

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡